These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34814396)

  • 1. [Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].
    Sun Y; Zhang HH; Zheng JS; Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1001-1005. PubMed ID: 34814396
    [No Abstract]   [Full Text] [Related]  

  • 2. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
    Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
    Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
    Yang Y; Xin Y; Ye F; Liu N; Zhang X; Wang Y; Li X; Fan Q; Zhou X; Chen Y
    Int J Hyperthermia; 2021; 38(1):437-446. PubMed ID: 33724137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.
    Yang Y; Chen Y; Zhang X; Xin Y; Wang Y; Li X; Fan Q; Zhou X; Ye F
    Eur J Radiol; 2021 May; 138():109623. PubMed ID: 33711573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    Lee YR; Park SY; Kim SU; Jang SY; Tak WY; Kweon YO; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Hur K
    J Gastroenterol Hepatol; 2017 May; 32(5):1079-1086. PubMed ID: 27859615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
    J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of hepatocellular carcinoma: CT texture analysis of the ablated area to predict local recurrence.
    Beleù A; Autelitano D; Geraci L; Aluffi G; Cardobi N; De Robertis R; Martone E; Conci S; Ruzzenente A; D'Onofrio M
    Eur J Radiol; 2022 May; 150():110250. PubMed ID: 35367776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
    Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
    World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.
    Qiu J; Chen S; Wu H
    J Surg Res; 2014 May; 188(1):14-20. PubMed ID: 24387841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Curative effect analysis of ultrasound-guided percutaneous radiofrequency ablation for caudate lobe hepatocellular carcinoma].
    Zhou YZ; Zhu RL; Wang ZZ; Yu KL; Li QJ; Zhou JX
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):690-695. PubMed ID: 34371541
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T; Hayashi S; Shimizu J; Dono K; Nakata S; Sato M; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2371-3. PubMed ID: 20037426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.